Market revenue in 2023 | USD 1,629.6 million |
Market revenue in 2030 | USD 3,021.9 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Hereditary non-cancer testing |
Fastest growing segment | Hereditary Cancer Testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hereditary Cancer Testing, Hereditary Non-cancer Testing |
Key market players worldwide | Myriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.
Hereditary non-cancer testing was the largest segment with a revenue share of 85.95% in 2023. Horizon Databook has segmented the Asia Pacific hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.
Major growth factors influencing Asia Pacific hereditary testing market include increasing fertility rates, rising burden of inherited genetic diseases, developing healthcare infrastructure, and growing awareness about benefits of prenatal testing & newborn screening.
The high birth rates of several developing economies in the region are responsible for an increase in several birth defects & genetic diseases in infants. As per ESCAP Online Statistical Database, 2018, the crude birth rate (births per 1,000 population) in the Asia Pacific region was 16.0 in 2018. The following figure shows the crude birth rate in different regions of Asia Pacific.
As per World Bank data, in 2016, India had a fertility rate of 2.23 births per woman, which is much higher than China’s 1.62 per woman, and 1.80 per woman in the U.S. Although India’s total fertility rate is steadily declining, its birthrate is still very high as compared to developed economies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account